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ChemotaxisTumor-inﬁltrating T lymphocytes are considered to facilitate development of Epstein–Barr virus (EBV)-
associated nasopharyngeal carcinoma (NPC), but how EBV in NPC tumor cells directs T cell inﬁltration remains
unclear. Here we compare EBV-infected NPC cells with and without spontaneous expression of viral latent
membrane protein 1 (LMP1) and ﬁnd that culture supernatants of LMP1-positive NPC cells exert enhanced
chemoattraction to primary T cells. Knockdown of endogenous LMP1 in the cells suppresses the chemotactic
activity. Endogenous LMP1 in NPC cells upregulates multiple chemokines, among which MIP-1α, MIP-1β and
IL-8 contribute to T cell chemotaxis.We further reveal that LMP1-induced production ofMIP-1α andMIP-1β in
NPC cells requires not only two carboxyl-terminal activation regions of LMP1 but also their downstreamNF-κB
and JNK pathways. This study corroborates that endogenous LMP1 in EBV-infected NPC cells induces multiple
chemokines to promote T cell recruitment and perhaps other pathogenic events in NPC.an 704, Taiwan. Fax: +886 6
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Epstein–Barr virus (EBV)-associated, undifferentiated nasopha-
ryngeal carcinoma (NPC) is also denominated lymphoepithelioma
because of its intensive inﬁltration of lymphocytes among EBV-
infected epithelial malignant cells (Rickinson and Kieff, 2007). In the
inﬂammation-like NPC tissues, most of intratumoral lymphocytes are
CD3-positive T cells with variable CD4 and CD8 composition
(Ferradini et al., 1991; Huang et al., 1999). The lymphoid stroma has
been considered to facilitate NPC development in several ways.
Inﬁltrating T lymphocytes may promote growth or survival of NPC
tumor cells through their membrane-bound ligands or secreted
cytokines (Agathanggelou et al., 1995; Huang et al., 1999; Sbih-
Lammali et al., 1999). Meanwhile, intratumoral regulatory T cells can
enhance local immunosuppression and help NPC cells to evade anti-
tumor immune response (Lau et al., 2007). In addition, high numbers
of certain T cells in NPC biopsies predict rapid fatal outcome aftercancer therapy (Oudejans et al., 2002), further underlining the clinical
impact of the lymphocytic inﬁltrates.
How T cells are recruited to NPC tissues has not been fully resolved.
The strong association of EBV infection with NPC raises a possibility
that EBVmay promote lymphocytic inﬁltration in the cancer. This idea
is encouraged by previous ﬁndings that in epithelial cell lines EBV
latent membrane protein (LMP)-1 induces some chemokines with
potentials to invoke immune cells (Buettner et al., 2007; Eliopoulos
et al., 1999; Morris et al., 2008; Yoshizaki et al., 2001). Serving as an
oncoprotein, LMP1 triggers multiple signaling pathways that potently
affect gene expression and cell functions (Kieser, 2007; Soni et al.,
2007; Tsao et al., 2002). However, due to several considerations, the
contribution of EBV LMP1 to chemokine production and T cell
chemotaxis in NPC has not come to conclusion. First, previous studies
generally used ectopic overexpression of LMP1 in EBV-negative
epithelial cells. It remains unclear whether endogenous LMP1,
expressed at a physiological level in the EBV-positive cell background,
also upregulates chemokines consistently. Second, epithelial cell lines
used in most of previous studies are not derived from NPC.
Considering that LMP1-mediated signal activation or gene regulation
appears to depend on cell types or cell lines (Kieser, 2007; Soni et al.,
2007), how LMP1 inﬂuences the expression proﬁle of chemokines in
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studies have not carried out a functional assay to evaluate if LMP1-
induced chemokines are responsible for recruitment of T lympho-
cytes, leaving a question unanswered whether these chemokines
attract T cells directly.
To address the above-mentioned issues in this study,we isolate and
compare EBV-infected NPC cell lines with and without spontaneous
LMP1 expression, examining the roles of endogenous LMP1 in T cell
recruitment and chemokine induction. Spontaneous LMP1 expression
in the cells is associated with enhancement of T cell chemoattraction,
and knockdown of the endogenous LMP1 suppresses the chemotactic
effect. Endogenous LMP1 in NPC cells upregulates a panel of secreted
chemokines, among which MIP-1α, MIP-1β and IL-8 contribute to
T cell chemotaxis in a functional assay. We further explore how LMP1
inducedMIP-1α andMIP-1β, revealing that the two carboxyl-terminal
regions of LMP1 and their downstream activation of NF-κB and JNK
pathways are required. These results corroborate that endogenous
LMP1 in EBV-infected NPC cells acts as a potent inducer of multiple
chemokines that functionally attracts T cells, thus potentially
promoting lymphocytic inﬁltration and facilitating NPC development.
Results
Expression of endogenous LMP1 in NPC cells is associated with enhanced
chemotaxis of T cells
Through in vitro infection using a recombinant Akata EBV expressing
enhanced green ﬂuorescence protein (EGFP) (Chang et al., 1999;Maruo
et al., 2001), we converted an EBV-negative NPC cell line HONE-1 to
EGFP/EBV-positive HONE-GV cells. Only a few of HONE-GV cellsFig. 1. Characterization of EBV-infected NPC cells with differential LMP1 expression and chem
HONE-GV8 cells but not in EBV-negative HONE-1 cells. (B) Intracellular copy numbers of E
independent assays. (C) Expression of LMP1, EBNA1 and β-actin in cell lysates was examined
(LCL) with a comparable cell number was used for comparison of LMP1 expression levels. (
supernatants to primary T cells. Shown is the summary from three independent experimenspontaneously expressed LMP1, so we isolated the LMP1-positive cells
(designated HONE-GV8) and compared them with the LMP1-negative
counterpart cells (designated HONE-GV2). The positive rates and
expression levels of EBV-encoded RNA (EBER) and EGFP were
comparable between HONE-GV2 and HONE-GV8 cells (Fig. 1A), and
intracellular copy numbers of EBV DNA were also similar (Fig. 1B,
around 13 to 15 EBV copies per cell). Both HONE-GV2 and HONE-GV8
cells expressed EBV nuclear antigen (EBNA)-1 (Fig. 1C), while EBNA2,
LMP2A and viral lytic proteins were undetectable therein (data not
shown). Spontaneous expression of LMP1 in HONE-GV8 but not in
HONE-GV2 cells was conﬁrmed by an immunoblotting assay, and the
expression level of LMP1 in HONE-GV8 cells was similar to that in EBV-
infected lymphoblastoid cells (Fig. 1C). To test whether the presence or
absence of endogenous LMP1 was associated with differential T cell
recruitment, we performed a chemotaxis assay using puriﬁed CD3-
positive primary T lymphocytes as target cells. The culture supernatants
of HONE-1 and HONE-GV2 cells attracted around 1000 T cells per well
within 30 min in the assay, at a level more efﬁcient than fresh medium.
Notably, the conditioned medium of LMP1-expressing HONE-GV8 cells
exerted signiﬁcantly enhanced chemoattraction to T cells (Fig. 1D). This
result provides a remarkable clue linking endogenous LMP1 inNPC cells
to T cell chemotaxis.
Knockdown of endogenous LMP1 in NPC cells suppresses T cell
chemotaxis
To test whether endogenous LMP1 expressed in HONE-GV8 cells
was responsible for enhancement of T cell recruitment, we carried out
small interfering RNA (siRNA)-mediated knockdown of LMP1. A
LMP1-specifc siRNA inhibited expression of endogenous LMP1 inoattraction to T cells. (A) EGFP and EBERwere detected in EBV-infected HONE-GV2 and
BV DNA were quantiﬁed by real-time PCR. Shown is the result summarized from four
by using an immunoblotting assay. An Akata EBV-transformed lymphoblastoid cell line
D) A chemotaxis assay was performed to study the chemotactic activity of cell culture
ts using T cells from different donors.
Fig. 2. The suppressive effect of a LMP1-targeted siRNA on T cell chemotaxis enhanced by HONE-GV8 cells. HONE-GV2 and HONE-GV8 cells were mock-transfected or transfected with a
control siRNA (siCtrl) or a LMP1-speciﬁc siRNA(siLMP1) for 72 h. (A)Expression of LMP1, EBNA1andβ-actin in cell lysateswasdetected byusingan immunoblotting assay. (B)Chemotactic
activity of the culture supernatants was examined in a chemotaxis assay. Shown is the summary from three independent experiments using T cells from different donors.
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By comparison, expression levels of endogenous LMP1 and EBNA1
were not affected by a control siRNA (Fig. 2A). Cells transfected with
these two siRNAswere equally viable and showed no difference in cell
proliferation (data not shown), indicating that endogenous LMP1
contributed little to growth or survival of the NPC cells. Notably, the
LMP1-specifc siRNA, not the control siRNA, signiﬁcantly abolished the
enhanced chemotactic effect of conditioned medium from HONE-GV8
cells, while the siRNA tranfection had no effect on the basal-level T cell
attraction directed by LMP1-negative HONE-GV2 cells (Fig. 2B). This
result indicates substantial contribution of endogenous LMP1 in NPC
cells to enhancement of T cell recruitment.Fig. 3. Proﬁles of chemokines secreted from HONE-GV2 and HONE-GV8 cells. Culture super
chemokines examined in the array are listed in the lower panel. Boxed are the chemokines si
HONE-GV2, including MIP-1α, MIP-1β, IL-8, GROα, and pan-GROs.Expression of endogenous LMP1 in NPC cells is associated with
upregulation of multiple chemokines
The LMP1-promoted T cell chemotaxis suggested that endoge-
nous LMP1 may induce certain chemotactic factors secreted from
NPC cells, so we used an antibody array to analyze chemokine
proﬁles in the culture supernatants of HONE-GV2 and HONE-GV8
cells (Fig. 3). Several chemokines were detected in HONE-GV2-
conditioned medium, including pan-GROs (containing GROα, GROβ
and GROγ), GROα, IL-8, IP-10, MDC, MIP-1α, MIP-1β, MIP-3α, NAP2,
and RANTES, which may account for the basal-level chemotactic
activity. Compared with LMP1-negative HONE-GV2 cells, LMP1-natants of the cells were analyzed by using a human chemokine antibody array. All the
gniﬁcantly increased in HONE-GV8-conditionedmedium compared with the medium of
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of MIP-1α, MIP-1β, IL-8, GROα, and pan-GROs. We further
performed enzyme-linked immunosorbent assay (ELISA) to conﬁrm
that HONE-GV8 cells secreted more MIP-1α, MIP-1β and IL-8 than
HONE-GV2 cells and EBV-negative HONE-1 cells (Fig. 4A), showing
an association of endogenous LMP1 with increase of multiple
chemokines from NPC cells.Endogenous LMP1 in NPC cells upregulates multiple chemokines that
attract T cells
To examine whether the elevated secretion of chemokines from
HONE-GV8 cells was attributed to LMP1, we knocked down the
endogenous LMP1 by siRNA and measured secretion of MIP-1α, MIP-
1β and IL-8 by ELISA. The LMP1-specifc siRNA, not the control siRNA,
signiﬁcantly reduced levels of these three chemokines in HONE-GV8-
conditioned medium, while the siRNA tranfection did not affect the
chemokine production from HONE-GV2 cells (Fig. 4B). As ELISA kits
for detection of individual GROs were not readily available, we
quantiﬁed transcripts of these chemokine genes by using reverse
transcription and real-time PCR. The mRNA levels of GROα, GROβ and
GROγ in HONE-GV8 cells were higher than those in HONE-GV2 cells,
and silencing of endogenous LMP1 suppressed transcription of the
three GRO genes in HONE-GV8 cells (Fig. 4C). Therefore, endogenous
LMP1 can contribute to upregulation of multiple chemokines in NPC
cells.
We further used neutralizing antibodies to evaluate whether the
chemokines upregulated by endogenous LMP1 can promote T cellFig. 4. Suppressive effects of a LMP1-targeted siRNA on chemokine expression of HONE-GV8 ce
ELISA. (B)HONE-GV2 andHONE-GV8cellswere transfectedwith indicated siRNAs for 72 h, and t
IL-8. (C) Cell transfection with siRNAs was performed as in panel B, and relative mRNA levels ofchemotaxis. While the T cell migration enhanced by HONE-GV8-
conditioned medium was not affected by a control antibody or an
antibody neutralizing pan-GROs, antibodies against MIP-1α, MIP-1β
and IL-8 signiﬁcantly reduced the chemotactic effect of the condi-
tioned medium (Fig. 5). The functional assay indicates that at least
three chemokines (MIP-1α, MIP-1β and IL-8) induced by endogenous
LMP1 in NPC cells can attract T lymphocytes.Two carboxyl-terminal regions of LMP1 are required for upregulation of
MIP-1α and MIP-1β
Among the three LMP1-induced, T cell-attracting chemokines,
IL-8 has been shown to be upregulated by LMP1 through NF-κB and
p38 MAPK signaling pathways (Eliopoulos et al., 1999; Ren et al.,
2004), but how LMP1 promotes expression of MIP-1α and MIP-1β
is unknown. Two carboxyl-terminal activation domains (CTARs) of
LMP1, CTAR1 and CTAR2, are responsible for many LMP1-triggered
events regarding signal transduction and gene regulation (Kieser,
2007; Soni et al., 2007), so we tested involvement of these two
regions in LMP1-mediated induction of MIP-1α and MIP-1β. EBV-
negative NPC cell lines, HONE-1 and NPC-TW01, were transfected
with plasmids expressing wild-type LMP1 or mutated LMP1 with
deletion at CTAR1, CTAR2 or both, and their secretion of MIP-1α
and MIP-1β was then quantiﬁed by ELISA. Production of MIP-1α
and MIP-1β from NPC cells was also increased by exogenous LMP1
that was expressed at a higher level than EBV-infected B cells
(Fig. 6). Compared with wild-type LMP1, deletion at either CTAR1
or CTAR2 signiﬁcantly impaired LMP1's ability to induce MIP-1αlls. (A) MIP-1α, MIP-1β and IL-8 in the cell culture supernatants were quantiﬁed by using
heir culture supernatantswere subjected to ELISA for quantiﬁcation ofMIP-1α, MIP-1β and
GROα, GROβ and GROγwere quantiﬁed by using reverse transcription and real-time PCR.
Fig. 5. Effects of chemokine-neutralizing antibodies on the T cell chemotaxis enhanced
by HONE-GV8 cells. As indicated, conditioned medium of HONE-GV2 and HONE-GV8
cells, and a control antibody (Ctrl Ab) or blocking antibodies against MIP-1α, MIP-1β,
IL-8 and pan-GROs were used in the chemotaxis assay. Shown is the summary from
three independent experiments. Signiﬁcant enhancement (#, Pb0.01) of T cell
chemotaxis by the conditioned medium of HONE-GV8 cells (as compared with the
medium of HONE-GV2) and signiﬁcant reduction (*, Pb0.05) of T cell migration by the
antibodies against MIP-1α, MIP-1β and IL-8 (as compared with treatment with the
control antibody) are indicated.
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complete loss of the function (Fig. 6). Therefore, both CTAR1 and
CTAR2, and very likely their downstream signaling pathways, are
important for LMP1 to upregulate MIP-1α and MIP-1β in NPC cells.
Meanwhile in a chemotaxis assay, the conditioned medium of
HONE-1 cells transiently transfected with a LMP1-expressing plasmid
attracted T cells more efﬁciently than the culture supernatants of
vector control cells (Fig. 7). Treatment with neutralizing antibodies
against MIP-1α, MIP-1β and IL-8 reduced the T cell migration (Fig. 7),
indicating that like endogenous LMP1, exogenous LMP1 can also
direct T cell chemoattraction through these chemokines.
NF-κB and JNK signaling pathways are required for LMP1-mediated
upregulation of MIP-1α and MIP-1β
Depending on cell types or cell lines, LMP1 can trigger various
signaling pathways, including canonical and noncanonical NF-κB, JNK,
p38 MAPK, PI-3 K/Akt and JAK/STAT pathways (Kieser, 2007; Soni et
al., 2007). We further screened what pathways can be stimulated by
LMP1 signiﬁcantly and consistently in two NPC cell lines, and revealed
that NF-κB and JNK were two major target pathways (Fig. 8A). LMP1
activated the NF-κB pathway in NPC cells, both canonical (marked by
reduction of IκBα and induction of NF-κB p100) and noncanonical
(represented by increase of NF-κB p52). Meanwhile, LMP1 also
induced phosphorylated/activated forms of p54/p46 JNK while did
not affect total JNK level. In addition, a transcription factor Ets-1 was
also consistently upregulated by LMP1 in NPC cells (Fig. 8A). We
further used LMP1 mutants to link individual CTARs to the
downstream signaling events. Deletion at CTAR1 diminished LMP1-
induced NF-κB p52, while deletion at CTAR2 abolished decrease of
IκBα and increase of NF-κB p100, Ets-1, and phosphorylated JNK
(Fig. 8B). Therefore, consistently with previous studies using other cell
lines (Eliopoulos and Young, 1998; Saito et al., 2003), CTAR1 is
required for activation of noncanonical NF-κB pathway, while CTAR2
is essential for activation of canonical NF-κB and JNK pathways in NPC
cells. On the other hand, CTAR2 is involved in induction of Ets-1 inNPC cells, which is different from a previous study suggesting the
involvement of CTAR1 (Kim et al., 2000).
Since LMP1-mediated induction of MIP-1α and MIP-1β required
CTAR1 and CTAR2 (Fig. 6) and the two CTARs mediated activation of
NF-κB and JNK and upregulation of Ets-1 (Fig. 8), next we examined
whether NF-κB, JNK and Ets-1 were essential for LMP1 to upregulate
MIP-1α and MIP-1β in NPC cells. LMP1-triggered induction of these
two chemokines was abrogated by treatment either with IκB kinase
inhibitor X that blocked both canonical and noncanonical NF-κB
pathways (Fig. 9A), or with a JNK inhibitor SP600125 that suppressed
phosphorylation/activation of JNK (Fig. 9B), indicating requirement
for both NF-κB and JNK signaling pathways in the chemokine
induction. On the other hand, siRNA-mediated knockdown of Ets-1
had little effect on the upregulation of MIP-1α and MIP-1β (Fig. 9C),
so Ets-1 may be dispensable herein.
Discussion
This is the ﬁrst study evaluating the contributions of endogenous
LMP1 in EBV-infected NPC cells to chemokine production and T cell
recruitment. Comparedwith LMP1-negative counterpart cells, NPC cells
with spontaneous expression of LMP1 show increased secretion of
multiple chemokines and enhanced chemoattraction to primary T cells.
In line with our previous study reporting that endoplasmic reticulum
stress-induced XBP-1 upregulates LMP1 inNPC cells (Hsiao et al., 2009),
an active form of XBP-1 is detected in the LMP1-positive HONE-GV8
cells but not in the LMP1-negative HONE-GV2 cells (data not shown).
Thus the intracellular stress and its downstream factorsmay account for
the differential expression of LMP1. Using siRNA silencing of LMP1 in
HONE-GV8 cells, we further verify that in the presence of the EBV
genome and viral latent gene products such as EBNA1 and EBER,
endogenous LMP1 acts as a critical factor for the enhancement of
chemokineproduction and T cell chemotaxis. Although previous studies
have indicated that EBNA1 also can induce certain chemokines
(Baumforth et al., 2008; O'Neil et al., 2008), EBV-negative HONE-1
cells and EBNA1-positive, LMP1-neagtive HONE-GV2 cells show similar
chemotactic activity and chemokine expression in this study. Even if we
cannot rule out that other EBV gene products may contribute to T cell
chemotaxis, our data corroborate that LMP1 in NPC cells serves as an
effective inducer of multiple chemokines that function to attract T cells.
Induction of chemokines by ectopic expression of LMP1 is likely to
depend on cell types or cell lines. For example, in B lymphoid cells,
LMP1 has been reported to induces IP-10 (Vockerodt et al., 2005),
RANTES (Uchihara et al., 2005), MIP-3α (Okudaira et al., 2006), TARC
and MDC (Nakayama et al., 2004), while in some epithelial cell lines,
LMP1 can drive production of IL-8 (Eliopoulos et al., 1999; Yoshizaki
et al., 2001), MCP-1 and RANTES (Buettner et al., 2007). In this study
we reveal that endogenous LMP1 in EBV-positive NPC cells upregu-
lates a panel of chemokines, including MIP-1α, MIP-1β, IL-8, GROα,
GROβ and GROγ, while it exerts little effect on other chemokines that
have been induced by LMP1 in either B cells or non-NPC epithelial
cells. Interestingly, EBV-infected lymphoblastoid cells highly express
MIP-1α and MIP-1β, but whether their expression is related to LMP1
in B cells remains controversial (Cahir-McFarland et al., 2004;
Nakayama et al., 2004). Meanwhile, a previous study usingmicroarray
analysis has found that exogenous LMP1 may augment transcription
of MIP-1β and GROs in keratinocytes, though their induction
mechanisms and biologic functions have not been further tested
(Morris et al., 2008). On the other hand, LMP1-induced expression of
MCP-1 has been reported in keratinocyte cell lines (Buettner et al.,
2007; Morris et al., 2008), but MCP-1 is undetectable in our NPC cells
regardless of expression of endogenous LMP1, recapitulating that the
regulatory effects of LMP1 on chemokines may have certain
differences among epithelial cells.
This study discloses that at least three chemokines upregulated by
endogenous LMP1 in NPC cells functionally enhance T cell
Fig. 6. Requirement for CTAR1 and CTAR2 in LMP1-induced expression of MIP-1α andMIP-1β. (A) HONE-1 cells were transfected with a vector plasmid or plasmids expressing wild-
type (wt) LMP1 or mutated LMP1 with deletion at CTAR2 (ΔCTAR2), CTAR1 (ΔCTAR1) or both (ΔCTAR12) for 48 h. Expression of LMP1 and β-actin was examined by using an
immunoblotting assay, and the production of MIP-1α and MIP-1β in the culture supernatants was quantiﬁed by using ELISA. (B) As in panel A, the same experiment was carried out
by using NPC-TW01 cells. (C) The expression levels of exogenous LMP1 were compared with that of Akata EBV-infected lymphoid cells in an immunoblotting assay.
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neutralization of MIP-1α, MIP-1β and IL-8, indicating that these
chemokines are involved in maximal LMP1-promoted recruitment of
T cells. MIP-1α and MIP-1β are evolutionarily related chemokines
with structural and functional similarities (Menten et al., 2002). They
are potent attractants for CD3-positive T cells with differential
preferences for T cell subsets: MIP-1α for CD8 cells and MIP-1β for
CD4 cells (Schall et al., 1993; Taub et al., 1993). They also stimulate
transendothelial migration of T cells (Roth et al., 1995). MIP-1β can
also attract regulatory T cells (Bystry et al., 2001), an immunosup-
pressive T cell subset that has been detected in NPC tissues (Lau et al.,
2007). Meanwhile, IL-8 can recruit certain subsets of CD8 T cells
expressing a high-afﬁnity IL-8 receptor CXCR1 (Gasser et al., 2005;
Hess et al., 2004). Therefore, through the multiple chemokines, LMP1
in NPC cells may cooperatively direct inﬁltration of various T cell
subsets in NPC tumors. In addition, LMP1 may potentially invoke
other immune cells through these chemokines, since MIP-1α is a
potent chemoattractant for monocytes and IL-8 is also for neutrophils
(Baggiolini et al., 1992; Uguccioni et al., 1995).
Our study does not exclude the possibility that some LMP1-
independent mechanisms may also regulate chemokine productionand T cell recruitment in NPC tumors. While a previous study has
indicated an association between LMP1 and IL-8 in NPC biopsies
(Yoshizaki et al., 2001), we did not identify correlation of LMP1
expression with MIP-1α or MIP-1β in NPC specimens (data not
shown). Thus some factors other than LMP1may also regulate the two
chemokines in NPC cells. For example, ligation of surface CD40
possibly triggers similar signaling pathways and induces some
chemokines as LMP1 does (Buettner et al., 2007). In addition, myeloid
stromal cells may produce MIP-1α and MIP-1β in NPC tumors (Tang
et al., 2001). On the other hand, as is shown in Fig. 3, both LMP1-
negative HONE-GV2 and LMP1-expressing HONE-GV8 cells secrete
comparable amounts of RANTES and some other chemokines with
potential to attract T cells. It suggests that NPC cells can direct
chemotaxis at certain level in the absence of LMP1. Once LMP1 is
expressed, however, induction of MIP-1α, MIP-1β and IL-8 can further
enhance recruitment of T cells. Interestingly, MIP-1α andMIP-1βmay
cooperate with RANTES to attract T cells since the three chemokines
share some common receptors (Balkwill, 2004; Menten et al., 2002).
Therefore, our data suggest that LMP1 can be an effective, albeit not
the only, factor that promotes T cell inﬁltration in NPC. However,
considering that other factors may substitute for LMP1 to induce
Fig. 7. Enhancement of T cell chemotaxis through chemokines induced by exogenous
LMP1 in NPC cells. HONE-1 cells were transfected with a vector plasmid or a LMP1-
expressing plasmid for 48 h and then the culture supernatantswere tested in a chemotaxis
assay. As indicated, a control antibody (Ctrl Ab) or antibodies blockingMIP-1α, MIP-1β or
IL-8 were added. Signiﬁcant enhancement (#, P≤0.01) of T cell chemotaxis by the
conditioned medium of LMP1-expressing cells and signiﬁcant reduction (*, P≤0.05) of
T cell migration by the antibodies against MIP-1α, MIP-1β and IL-8 are shown.
470 H.-C. Lai et al. / Virology 405 (2010) 464–473chemokine production and T cell recruitment in NPC tumors, an
alternative hypothesis remains claimable that LMP1 may not be
always playing a signiﬁcant role in lymphoid inﬁltration in vivo.
This study also unveils the signaling pathways through which
LMP1 induces MIP-1α and MIP-1β. Depending on cellular back-
grounds and stimuli, expression of MIP-1α and MIP-1β can be co-
regulated by various signaling pathways and transcription factors. For
example, in human neutrophils activated by tumor necrosis factor or
lipopolysaccharide, induction of MIP-1α and MIP-1β requires NF-κB,
p38 MAPK and ERK (Cloutier et al., 2007), while CCAAT/enhancer-
binding proteins are involved in Fcγ receptor-induced expression of
MIP-1α andMIP-1β in monocytic cells (Fernandez et al., 2002). In this
study we verify that NF-κB and JNK are the pathways consistently
activated by LMP1 in NPC cells and essential for induction of MIP-1α
and MIP-1β. The promoters of MIP-1α and MIP-1β genes contain not
only DNA elements for binding of NF-κB but also elements for AP-1,
the transcription factor targeted by JNK (Grove and Plumb, 1993;
Tseng et al., 2008; Widmer et al., 1993). Thus LMP1 may stimulate
both promoters through activation of the signaling pathways and
their downstream transcription factors. On the other hand, although
the MIP-1α promoter contains an Ets-binding element (Grove and
Plumb, 1993), LMP1-induced Ets-1 has little contribution to upregu-
lation of MIP-1α and MIP-1β in NPC cells.
In addition to chemotactic functions, the LMP1-upregulated
chemokines may contribute to cancer development in other ways.
For instance, MIP-1α and MIP-1β can promote clonogenic growth of
Hodgkin's lymphoma cells (Aldinucci et al., 2008). MIP-1α and its
receptor CCR1 are aberrantly expressed in human hepatocellular
carcinoma, and they are important for tumor growth and
angiogenesis in related animal models (Yang et al., 2006). The
effects of IL-8 and GROα on tumor growth, angiogenesis and
metastasis in many cancers have also been documented (Caunt
et al., 2006; Inoue et al., 2000; Wang et al., 2006; Yoshizaki et al.,
2001). Moreover, a previous study has shown that MIP-1β plays a
role in inhibition of T cell activation (Joosten et al., 2007),
potentially linking this chemokine to local immunosuppresion in
tumor tissues. Although most of the mentioned effects have notbeen examined in NPC, we speculate that LMP1 may affect a broad
spectrum of tumorigenic events in NPC through these upregulated
chemokines.Materials and methods
Cell culture
Two EBV-negative NPC cell lines (NPC-TW01 and HONE-1) and
EBV-immortalized lymphoblastoid cells were cultured as described
previously (Chang et al., 2004b; Hsiao et al., 2009). HONE-1 cells were
subjected to infection with a recombinant EGFP-expressing Akata EBV
(Maruo et al., 2001). The infection procedure and subsequent isolation
of the EBV-infected HONE-GV cell clones through limiting dilution
were carried out according to previous studies (Chang et al., 2004a,
1999). EGFPwas detected under a ﬂuorescencemicroscope (Olympus,
Tokyo, Japan), while expression of LMP1 was examined by using an
immunoblotting assay. Virus-converted cell clones with and without
LMP1 expression were separately pooled and designated HONE-GV8
and HONE-GV2, respectively, both of which were maintained in
complete medium with G418 (400 μg/ml).EBER in situ hybridization
Cells were pelleted, ﬁxed in 10% formalin, dehydrated, and
embedded into parafﬁn blocks. Block sections on silanized slides
were deparafﬁnized, rehydrated, and digested with proteinase
K (10 μg/ml) in 0.1 M Tris at 37 °C for 30 min. The slides were then
hybridized with the ﬂuorescein-conjugated EBER DNA probe, devel-
oped by using an ISH detection kit (Novocastra Laboratories,
Newcastle upon Tyne, United Kingdom), colorized through reaction
with a BCIP/NBT kit (Zymed Laboratories, South San Francisco, CA),
and counterstained with eosin. The positivity of EBER hybridization
was examined under a light microscope (Olympus).Quantiﬁcation of intracellular EBV DNA
Cells (1×104/μl,) were lysed and digested in the lysis buffer (10 mM
Tris-HCl, 2.5 mM MgCl2, 1% Tween-20, 1% NP-40, and 1 mg/ml
proteinase K) at 50 °C overnight. The cell lysates were then subjected
to real-time PCR to quantify intracellular EBV DNA by using LightCycler
reagents and detection system (Roche Applied Science, Mannheim,
Germany). Primers (5'-TCATCATCATCCGGGTCTCC-3' and 5'-CCTA-
CAGGGTGGAAAAATGGC-3') and the probe (FAM-5'-CGCAGGCCCCCTC-
CAGGTAGAA-3'-TAMRA) were used to detect EBNA1 gene of the EBV
genome. H2B4 cells harbouring one integrated EBV genome per cell
were used as a reference for quantiﬁcation of EBV copy numbers (Chang
et al., 2004a, 2002).Immunoblotting assay
Cells were lysed, resolved by electrophoresis, and analyzed in an
immunoblotting assay as described previously (Hsu et al., 2008). The
primary antibodies used in the assay included mouse monoclonal
antibodies recognizing LMP1 (Hsiao et al., 2009), β-actin (Chemicon,
Temecula, CA), NF-κB p100/p52 (Upstate, Charlottesville, VA),
phosphorylated JNK at Thr183/Tyr185 (Cell Signaling, Beverly, MA)
and Ets-1 (Santa Cruz Biotechnology, Santa Cruz, CA), rabbit
antibodies recognizing total JNK (Cell Signaling) and IκBα (Santa
Cruz Biotechnology), and a human serum with high titers of anti-
EBNA1 IgA (Chang et al., 1999). The corresponding secondary
antibodies conjugated with horseradish peroxidase were purchased
from Jackson Immunoresearch (West Grove, PA).
Fig. 8. LMP1-triggered induction of signaling pathways and transcription factors in NPC cells. (A) NPC-TW01 and HONE-1 cells were transfected with a vector plasmid or a plasmid
expressing LMP1 for 24 h. The cell lysates were subjected to an immunoblotting assay detecting LMP1, IκBα, NF-κB p100, NF-κB p52, phosphorylated JNK (p-JNK) at Thr183/Tyr185,
total JNK, Ets-1 and β-actin. (B) NPC-TW01 cells were transfected with a vector plasmid or plasmids expressing wild-type (wt) LMP1 or mutated LMP1 with deletion at CTAR2
(ΔCTAR2), CTAR1 (ΔCTAR1) or both (ΔCTAR12) for 24 h. The cell lysates were subjected to an immunoblotting assay detecting the indicated proteins.
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Human whole blood was obtained from Taiwan Blood Service
Foundation (Tainan Blood Center), with the approval of Research Ethics
Committee of National Health Research Institutes (EC0971201-E). After
Ficoll centrifugation of human whole blood, we collected mononuclear
cells and further puriﬁed primary T cells through positive selection of
CD3 cells by using magnetic microbeads (Miltenyi Biotec, Bergisch
Gladbach, Germany). Purity of the T cells was conﬁrmed in that more
than 95% of selected cells were positive for CD3 in ﬂow cytometry. The
puriﬁedprimary T cellswere then subjected to the transwell chemotaxis
assay to test the chemotactic activity of cell culture supernatants. The
supernatants (600 μl/well) were applied to the lower chambers of
transwells (5-μm pore size; Corning, Acton, MA) in 24-well plates, and
T cells (1×106 in 200 μl serum-free medium/well) were added to the
upper chambers. After incubation for 30 min, cells migrating into the
lower chamberswere collectedand counted. In an indicated experiment
evaluating contribution of individual chemokines, culture supernatants
were preincubated with neutralizing antibodies or a control mouse
antibody (R&D Systems,Minneapolis, MN) at a concentration 25 μg/ml.
T cells from at least three healthy donors were used and each assay was
performed in duplicated wells.
Cell transfection and inhibitor treatment
The plasmids expressing LMP1 mutants with deletion of CTAR1
(amino acid residuals 189-222), CTAR2 (amino acid residuals 351-386) or both have been used previously (Liu et al., 2005). LMP1-
targeted siRNA was purchased from Invitrogen (Carlsbad, CA) and the
siRNA targeted against Ets-1 was from Santa Cruz Biotechnology. Cell
transfection with plasmid DNA and/or siRNA was performed by using
Lipofectamine 2000 reagent (Invitrogen) as described in our previous
study (Hsu et al., 2008). In indicated experiments, we treated cells
with 10 μM IκB kinase inhibitor X or 10 μM JNK inhibitor SP600125
(Calbiochem, San Diego, CA) at 4 h posttransfection. Cell lysates and
culture supernatants were collected at 24, 48 or 72 h posttransfection
for further analysis.
Antibody array and ELISA
Proﬁles of chemokines in the conditioned medium of 3-day-
cultured cells were analyzed by using a human chemokine antibody
array (RayBiotech, Norcross, GA) according to manufacturers’ in-
struction. After calibration with positive controls, secretion levels of
individual chemokines from HONE-GV2 and HONE-GV8 cells were
compared. The concentrations of MIP-1α, MIP-1β and IL-8 in the
culture supernatants were further measured by using DuoSet ELISA
development system (R&D Systems). Each sample was examined in
duplicate.
Quantitative reverse transcription-PCR
Total cellular RNAs were extracted by using a QIAamp RNA kit
(QIAGEN, Hilden, Germany) and subjected to reverse transcription
Fig. 9. Involvement of NF-κB and JNK pathways in LMP1-induced expression of MIP-1α and MIP-1β. NPC-TW01 cells were transfected with a vector plasmid (V) or a plasmid
expressing LMP1 (L) in conjunction with treatment with kinase inhibitors or cotranfection with siRNAs for 24 h. (A) The transfected cells were untreated (Ctrl) or treated with the
solvent DMSO or 10 μM IκB kinase inhibitor X (IKK X). (B) The transfected cells were untreated (Ctrl) or treatedwith the solvent DMSO or 10 μM JNK inhibitor SP600125 (SP). (C) The
transfected cells were cotranfected with a control siRNA (siCtrl), an Ets-1-speciﬁc siRNA (siEts1) or no siRNA (mock). The expression of indicated proteins was examined by using an
immunoblotting assay, and MIP-1α and MIP-1β in the culture supernatants were quantiﬁed by using ELISA.
472 H.-C. Lai et al. / Virology 405 (2010) 464–473by using the oligo(dT)15 primer and Superscript III reverse
transcriptase (Invitrogen) according to manufacturer's protocol.
The cDNAs of GRO chemokines were quantiﬁed by real-time PCR
using LightCycler reagents and detection system (Roche Applied
Science). PCR primers for detecting GROα were 5'-TCCTGCATCCCC-
CATAGTTA-3' and 5'-CTTCAGGAACAGCCACCAGT-3', and the locked
nucleic acid-based probe was 5'-GGAGGAAG-3’. Primers for detecting
GROβ were 5'-CATCGAAAAGATGCTGAAAAATG-3' and 5'-TTCAGGAA-
CAGCCACCAATA-3', and the correspondingprobewas 5'-GGAGGAAG-3'.
Primers for detecting GROγ were 5'-AAAATCATCGAAAAGATACTGAA-
CAA-3' and 5'-GGTAAGGGCAGGGACCAC-3', and the probe was 5'-
CTTCCTGC-3'. The RNA level of TATA box-binding protein was used as a
reference for internal calibration (primers: 5'-GCTGGCCCATAGT-
GATCTTT-3' and 5'-TCCTTGGGTTATCTTCACACG-3'; probe: 5'-CCCAG-
CAG-3'). Calculation of relative expression levels was carried out by
using the LightCycler software (Roche Applied Science). Each experi-
ment was performed in duplicate.Acknowledgments
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